TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04025138

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neuromuscular fatigue assessment test
Description: Neuromuscular fatigue assessment test in dynamic mode will be assessed by the Force/Velocity Profile (FVP) measure: 2 sprints of 8 seconds on a cycle ergometer.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neuromuscular fatigue assessment test
Description: Neuromuscular fatigue assessment test in dynamic mode will be assessed by the Force/Velocity Profile (FVP) measure: 2 sprints of 8 seconds on a cycle ergometer.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neuromuscular fatigue assessment test
Description: Neuromuscular fatigue assessment test in dynamic mode will be assessed by the Force/Velocity Profile (FVP) measure: 2 sprints of 8 seconds on a cycle ergometer.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neuromuscular fatigue assessment test
Description: Neuromuscular fatigue assessment test in dynamic mode will be assessed by the Force/Velocity Profile (FVP) measure: 2 sprints of 8 seconds on a cycle ergometer.
Study: NCT01703130

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dose of of ropivacaine 0.75% used in block procedure
Study: NCT01685528

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CBT
Description: 6-8 weekly sessions of CBT, 1 of which is in person with the rest being over the telephone
Study: NCT02274493

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: da Vinci® Robotic Surgical System
Description: Da Vinci Robotic Surgical system to be used in procedures that harvest the latissimus dorsi muscle for reconstructive procedures

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: LD muscle flap harvest procedure
Description: Latissimus dorsi muscle flap harvest procedure using da Vinci® Robotic Surgical System for use in reconstructive surgery.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Reconstructive surgery
Description: Reconstructive surgery is considered to be standard of care.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: Questionnaire about pain, as well as participant's shoulder, arm, and hand range of motion completed at baseline, and at follow up visits 3-6.
Study: NCT01295918

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: L reuteri in children on antibiotics
Description: Each patient will be assigned to receive either a probiotic supplement containing 1 x 10 8 CFU Lactobacillus reuteri DSM 17938 in the form of one chewable tablet once per day (BioGaia AB, Stockholm, Sweden) or placebo, identical in taste and appearance. The probiotic or placebo will be taken 2 hours after lunch each day, during the entire period of antibiotic treatment and for an additional 7 days.
Study: NCT03014830

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Alirocumab
Description: 150 mg SQ every 2 weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebos
Description: Placebo injections SQ every 2 weeks
Study: NCT01616654

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CD5789 25 µg/g cream
Description: CD5789 25 µg/g cream applied once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CD5789 50 µg/g cream
Description: CD5789 50 µg/g cream applied once daily

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: CD5789 100 µg/g cream
Description: CD5789 100 µg/g cream applied once daily

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Tazarotene 0.1% gel
Description: Tazarotene 0.1% gel applied once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vehicle cream
Description: Vehicle cream applied once daily
Study: NCT03728595

Intervention type: DIAGNOSTIC_TEST
Intervention: Venepuncture
Description: A blood sample will be taken for serum bicarbonate

Intervention type: DIAGNOSTIC_TEST
Intervention: Spirometry
Description: All patients who have not had a spirometry in the 12 months prior to the HAST will undergo one on the day of the HAST.

Intervention type: DIAGNOSTIC_TEST
Intervention: Hypoxic altitude simulation test (HAST)
Description: HAST will be performed as per clinical team request. No changes to this intervention will be made for research purposes.
Study: NCT01743963

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: clinicians typical apporach for GID monitering
Study: NCT00360243

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: flibanserin
Description: Experimental: flibanserin 25 mg b.i.d

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: flibanserin
Description: Experimental: flibanserin 50mg qhs
Study: NCT04025138

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: treadmill
Description: 2 sessions of treadmill will be realized: 8 and 10 km.h-1 for level running and 7 km.h-1 with 10% slope for graded running.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: treadmill
Description: 2 sessions of treadmill will be realized: 8 and 10 km.h-1 for level running and 7 km.h-1 with 10% slope for graded running.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: treadmill
Description: 2 sessions of treadmill will be realized: 8 and 10 km.h-1 for level running and 7 km.h-1 with 10% slope for graded running.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: treadmill
Description: 2 sessions of treadmill will be realized: 8 and 10 km.h-1 for level running and 7 km.h-1 with 10% slope for graded running.
Study: NCT00360243

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: flibanserin
Description: Experimental: flibanserin 50mg b.i.d.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo
Study: NCT03739463

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: MAG-DHA
Description: 375 MG of MAG-DHA per capsules, two capsules BID

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Oleic acid
Description: 375 MG of sunflower oil (oleic acid) per capsules, two capsules BID
Study: NCT00285298

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pentoxifylline

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT04105556

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nursing Care Based on Kolcaba's Comfort Theory
Description: In this study, nursing care based on Kolcaba's Comfort Theory, which continues throughout the perioperative period, was applied to children and their parents.
Study: NCT01847833

Intervention type: OTHER
Intervention: MRI scan
Study: NCT00868959

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lurasidone
Description: Lurasidone 20-120 mg/d Flexibly Dosed - 24 weeks
Study: NCT02596711

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine Patch
Description: Participants receive 4 weeks of 21 mg, 4 weeks of 14 mg, and 4 weeks of 7 mg patches.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine Patch
Description: Participants receive 4 weeks of 21 mg, 4 weeks of 14 mg, and 4 weeks of 7 mg patches.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine Patch
Description: Participants receive 4 weeks of 21 mg, 4 weeks of 14 mg, and 4 weeks of 7 mg patches.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: Questionnaires regarding tobacco and alcohol use, culture, religion, and sense of control completed at baseline, at weeks 2 and 6, and at 3 and 6 months after baseline.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: Questionnaires regarding tobacco and alcohol use, culture, religion, and sense of control completed at baseline, at weeks 2 and 6, and at 3 and 6 months after baseline.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: Questionnaires regarding tobacco and alcohol use, culture, religion, and sense of control completed at baseline, at weeks 2 and 6, and at 3 and 6 months after baseline.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Carbon Monoxide (CO) Test
Description: Carbon monoxide (CO) test given at baseline, at weeks 2 and 6, and at 3 and 6 months after baseline.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Carbon Monoxide (CO) Test
Description: Carbon monoxide (CO) test given at baseline, at weeks 2 and 6, and at 3 and 6 months after baseline.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Carbon Monoxide (CO) Test
Description: Carbon monoxide (CO) test given at baseline, at weeks 2 and 6, and at 3 and 6 months after baseline.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Education and Handouts
Description: Participants receive general health education and handouts.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Culturally Tailored Reading Materials
Description: Participants given reading materials that highlight how aspects of their culture relate to health, smoking and quitting.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Culturally Tailored Reading Materials
Description: Participants given reading materials that highlight how aspects of their culture relate to health, smoking and quitting.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Counseling Sessions
Description: Participants attend 3 counseling sessions during the study.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Counseling Sessions
Description: Participants attend 3 counseling sessions during the study.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Counseling Sessions
Description: Participants attend 3 counseling sessions during the study.
Study: NCT00563004

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: DBCARE
Description: Patients receive dbcare 2 tablets TID for 3 months

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: DBCARE
Description: PLACEBO PILLS 2 TABLETS TID FOR 3 MONTHS
Study: NCT04544709

Intervention type: DRUG
Group type: OTHER
Intervention: Low back intradiscal injection of platelet rich plasma (PRP)
Description: SOC Intradiscal Lumbar PRP Procedure : A small amount of blood is drawn from you, then it is spun in a centrifuge to obtain only the platelets and few other cells. After being spun the small amount of platelets will be injected into the specific disc that is believed to be causing pain in an attempt to help reduce inflammation and pain at the site. The injection will be done under fluoroscopic guidance (x-ray) that allows very careful and precise placement of the needle.
Study: NCT01465711

Intervention type: PROCEDURE
Intervention: All abdominal surgical procedures
Description: Laparotomy, Laparoscopy

Intervention type: PROCEDURE
Intervention: All abdominal surgical procedures
Description: Laparotomy, Laparoscopy

Intervention type: PROCEDURE
Intervention: Intubation
Description: Ventilatory support

Intervention type: PROCEDURE
Intervention: Intubation
Description: Ventilatory support

Intervention type: RADIATION
Intervention: Imaging
Description: Abdominal ultrasound Computer Tomography Magnetic Resonance Imaging

Intervention type: RADIATION
Intervention: Imaging
Description: Abdominal ultrasound Computer Tomography Magnetic Resonance Imaging
Study: NCT02730507

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Surgery with patient-specific rod
Description: Bras A: PSRs must be used with the appropriate instrumentation designed by the same manufacturer. In order to minimize potential bias derived from using different spinal systems or reduction techniques, the posterior instrumentation must be the same (except the use of standard straight rod) in both groups. The surgical method to implement the PSR will be the same as the one to implement the conventional rod. Except for the bending procedure (patient specific rod or conventional rod with perioperative manual bending), the characteristics of implantable devices (biomaterial and diameter of the rod, design, type of screw, etc.) will be the same in each center.
Study: NCT04900142

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Micropulsed laser trabeculoplasty
Description: Trabeculoplasty

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Micropulsed laser trabeculoplasty
Description: Trabeculoplasty
Study: NCT03180905

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ImPACT Online/Paper Pencil Tests
Description: Compare ImPACT Online versus Paper and Pencil Neurocognitive Tests

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ImPACT Online
Description: ImPACT Online will be administered at 2 time points.
Study: NCT00798096

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fostamatinib Disodium
Description: 200 mg PO BID
Study: NCT04025138

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Blood sample
Description: Blood sample will be realized to measure hemorrheologic and hematologic parameters.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Blood sample
Description: Blood sample will be realized to measure hemorrheologic and hematologic parameters.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Blood sample
Description: Blood sample will be realized to measure hemorrheologic and hematologic parameters.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Blood sample
Description: Blood sample will be realized to measure hemorrheologic and hematologic parameters.
Study: NCT03080792

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental: moderate to high-intensity exercise
Description: 2x per week endurance exercise (continuous moderate and high intensity intervall training on a cycle ergometer) and progressive resistance training (machine based hypertrophy training)
Study: NCT03012919

Intervention type: OTHER
Group type: OTHER
Intervention: active decision support system
Description: The active decision support system in this study is a goal directed therapy (GDT) protocol where threshold hemodynamic values are defined when to give fluid, vasopressors and inotropes. Hemodynamic values are measured with the LiDCOrapid device, which uses pulse contour analysis to continuously monitor cardiac output and respiratory variations in stroke volume (SVV).
Study: NCT00522756

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate
Description: Three ampoules of 7.5% sodium bicarbonate (89.3 mOsm/ampoule; total 150 ml for three ampoules) added to 750 ml of 5% dextrose in water, given at 1 ml/kg/hour through a dedicated intravenous line for 6 hours, and completed prior to the initiation of cardiopulmonary bypass.
Study: NCT04025138

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Urinary sample
Description: Urinary sample will be realized to measure hemorrheologic and hematologic parameters.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Urinary sample
Description: Urinary sample will be realized to measure hemorrheologic and hematologic parameters.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Urinary sample
Description: Urinary sample will be realized to measure hemorrheologic and hematologic parameters.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Urinary sample
Description: Urinary sample will be realized to measure hemorrheologic and hematologic parameters.
Study: NCT00522756

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sodium chloride
Description: 0.9% sodium chloride given at 1 ml/kg/hour through a dedicated intravenous line for 6 hours, and completed prior to the initiation of cardiopulmonary bypass.
Study: NCT00768781

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mindfulness-Based Stress Reduction
Description: The rationale for treatment is that MBSR targets arousal, which is a prominent perpetuating factor of insomnia. Each session meets weekly for 120 minutes and consists of a therapist-led mindfulness meditation, followed by a discussion of the meditation and its application into the participant's everyday life. For homework, each participant is required to practice formal meditation at least 45 minutes a day, 6 days per week. Participants will be provided a tape, an mp3 file, or CD to aid in the participant's personal practice at home. Formal meditations that will be led and discussed include eating meditation, body scan, sitting meditation, Hatha Yoga, and walking meditation. In addition, informal mindfulness practices will be discussed.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mindfulness-Based Therapy for Insomnia
Description: MBTI treatment includes the hypothesized active elements of both mindfulness meditation and behavior therapy for insomnia. The intervention includes 8 weekly sessions. Each session meets weekly for approximately 120 minutes. The general format of each session includes formal mindfulness meditation (quiet and movement meditations) and instructions for the behavioral intervention, with a focus on integrating the principles of mindfulness with these instructions. Each participant is required to practice formal meditation for at least 45 minutes a day, 6 days per week as homework. Participants are provided a tape, mp3 file, or CD to aid in the participant's personal practice at home.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Wait-List + Behavioral Therapy for Insomnia
Description: This delayed treatment condition consists of an 8-week monitoring period (sleep diaries, PSAS) and then BT. The BT treatment consists of 8 sessions of behavioral interventions for insomnia, with instructions targeting the nighttime symptoms of insomnia. The primary components of this treatment package are stimulus control, sleep restriction, and sleep hygiene education. In the BT condition, each weekly session lasts 120 minutes and consists of formal instructions for the behavioral interventions along with a time for discussion of the application of these instructions into each participant's unique circumstances.
Study: NCT02261688

Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Low salt diet
Description: Low salt diet, 10mmoL of sodium per day, for 6 days

Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Low salt diet + IV normal saline
Description: Low salt diet, 10 mmoL of sodium per day, for 4 days with normal saline infusion x 12 hours per day for 200 mmoL of sodium chloride. Total daily sodium is 210 mmoL/day.

Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Liberal salt diet
Description: Liberal salt diet targeting 200 mmoL of sodium per day x 7 days
Study: NCT00620217

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: intramyocardial injection of VEGF-A165/bFGF:placebo plasmid
Description: The plasmid will be given at a total dose of 0.5 mg, 10 injections of 0,2 ml each into the region of reversible ischemia. The process of injecting the solution into each of ten points within the ischemic zone will take 20 to 40 seconds to minimize muscle disruption

Intervention type: GENETIC
Group type: PLACEBO_COMPARATOR
Intervention: intramyocardial injection of VEGF-A165/bFGF:placebo plasmid
Description: The plasmid will be given at a total dose of 0.5 mg, 10 injections of 0,2 ml each into the region of reversible ischemia. The process of injecting the solution into each of ten points within the ischemic zone will take 20 to 40 seconds to minimize muscle disruption
Study: NCT03558204

Intervention type: PROCEDURE
Intervention: Denervation of the thumb CMC joint
Description: Removal/disconnection of the nerve branches to the joint from their attachments to the joint

Intervention type: PROCEDURE
Intervention: trapeziectomy with ligament reconstruction (LRTI)
Description: excision of the trapezium and suspension of the thumb metacarpal with the flexor carpi radialis tendon
Study: NCT04604873

Intervention type: OTHER
Group type: OTHER
Intervention: Hospital day care follow-up
Description: Regular follow up every month in hospital day care
Study: NCT01535989

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Inotuzumab Ozogamicin
Description: starting dose 0.8 mg/m2, d1 administration, q4wks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temsirolimus
Description: starting dose of 15mg, weekly administration, q4ws
Study: NCT02716649

Intervention type: OTHER
Intervention: No intervention
Study: NCT03168204

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tailored care and support
Description: Offering tailored care and support whereby the competences, strengths and resources of the older person are taken into account.The intervention will be an enhancement of usual care and will depend on the availability of the municipality, and could be formal (i.e., home care) or informal (e.g. activities of an older adult's association).
Study: NCT01859312

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (Solucortef)
Description: Continuous subcutaneous hydrocortisone infusion (CSHI) via Medtronic insulin pump (MMT-722NA). Total daily hydrocortisone dose was calculated based on the patient's estimated cortisol clearance. Rates were established to achieve peak and trough concentrations within the normal circadian cortisol range.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Insulin pump (Medtronic)
Description: Continuous subcutaneous hydrocortisone infusion (CSHI) via Medtronic insulin pump (MMT-722NA)
Study: NCT02023554

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Theophylline with azithromycin
Description: Drug: Theophylline(100mg,sustained release tablets). Multi-dose of theophylline(100mg,twice daily) will administered at 8 am and 8 pm from day 1 to day 7.~Drug:Azithromycin(250mg, capsules). Multi-dose of azithromycin(500mg,once daily) will administered at 8 pm from day 1 to day 7.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Theophylline alone
Description: Drug: Theophylline(100mg,sustained release tablet). Multi-dose of theophylline(100mg,twice daily) will administered at 8 am and 8 pm from day 8 to day 14.
Study: NCT02087306

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brincidofovir
Description: BCV administered twice weekly, dose depending on weight.
Study: NCT02960542

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HELP Prevent Cancer Intervention
Description: This Behavioral: Lifestyle Weigh Loss Intervention involves a dietary weight-loss program and an increase in caloric expenditure through moderate physical activity. The primary treatment objectives for the weight-loss component of the intervention will be to decrease caloric intake in a nutritionally sound manner so as to produce a weight-loss of .3 kg/week for a total weight loss of 5-7%. The primary objective for the physical activity component of the intervention will be to promote an increase in home-based energy expenditure to an eventual goal of 180 minutes/week.
Study: NCT01762241

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home based training using the Xbox Kinect system
Description: Home based training 3 times a week for 12 weeks using the Xbox Kinect system